Hansoh Pharmaceutical Group Company Ltd HNSPF
$4.11
Last Updated: Aug 07, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
HNSPF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Hansoh Pharmaceutical Group Company Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Hansoh Pharmaceutical Group Company Ltd. Stock Analysis HNSPF
United States Health Care Large Cap Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,347 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
Hansoh Pharmaceutical Group Company Ltd (HNSPF) Chart
Financial Metrics & Statements of Hansoh Pharmaceutical Group Company Ltd (HNSPF)
FAQ's for Hansoh Pharmaceutical Group Company Ltd (HNSPF)
- As of August 2026, Hansoh Pharmaceutical Group Company Ltd HNSPF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hansoh Pharmaceutical Group Company Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Hansoh Pharmaceutical Group Company Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Hansoh Pharmaceutical Group Company Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Hansoh Pharmaceutical Group Company Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Hansoh Pharmaceutical Group Company Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Hansoh Pharmaceutical Group Company Ltd (HNSPF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
